Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2000 2
2001 4
2002 3
2004 1
2005 3
2006 1
2007 3
2008 2
2009 1
2011 4
2012 4
2013 3
2014 1
2015 5
2016 9
2017 3
2018 3
2019 2
2020 6
2021 13
2022 9
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Comprehensive mastocytosis data analysis from a single center.
Tiryaki TO, Özkan SG, Erdem S, Aday AD, Hindilerden İY, Gelincik A, Baykal C, Yegen G, Doğan İÖ, Büyükbabani N, Nalçacı M, Yavuz AS. Tiryaki TO, et al. Among authors: nalcaci m. BMC Cancer. 2023 Jan 24;23(1):82. doi: 10.1186/s12885-022-10498-3. BMC Cancer. 2023. PMID: 36694141 Free PMC article.
Coexistence of chronic neutrophilic leukemia with multiple myeloma.
Dinçol G, Nalçaci M, Doğan O, Aktan M, Küçükkaya R, Ağan M, Dinçol K. Dinçol G, et al. Among authors: nalcaci m. Leuk Lymphoma. 2002 Mar;43(3):649-51. doi: 10.1080/10428190290012218. Leuk Lymphoma. 2002. PMID: 12002774 Review.
COVID-19 infection in patients with acute leukemia; Istanbul experience.
Buyuktas D, Acar K, Sucak G, Toptas T, Kapucu I, Bekoz H, Erdem S, Nalcaci M, Atalay F, Akay MO, Ferhanoglu B. Buyuktas D, et al. Among authors: nalcaci m. Am J Blood Res. 2021 Aug 15;11(4):427-437. eCollection 2021. Am J Blood Res. 2021. PMID: 34540352 Free PMC article.
Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis.
Tiryaki TO, Yönal Hindilerden İ, Yegen G, Nalçacı M. Tiryaki TO, et al. Among authors: nalcaci m. Turk J Haematol. 2020 May 6;37(2):130-131. doi: 10.4274/tjh.galenos.2020.2019.0186. Epub 2020 Mar 4. Turk J Haematol. 2020. PMID: 32126743 Free PMC article. No abstract available.
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.
Uncu Ulu B, Dal MS, Yönal Hindilerden İ, Akay OM, Mehtap Ö, Büyükkurt N, Hindilerden F, Güneş AK, Yiğenoğlu TN, Başcı S, Kızıl Çakar M, Yanardağ Açık D, Korkmaz S, Ulaş T, Özet G, Ferhanoğlu B, Nalçacı M, Altuntaş F. Uncu Ulu B, et al. Among authors: nalcaci m. J Chemother. 2022 May;34(3):190-198. doi: 10.1080/1120009X.2021.1976912. Epub 2021 Sep 13. J Chemother. 2022. PMID: 34514960
82 results